Thrivent Financial For Lutherans Tg Therapeutics, Inc. Transaction History
Thrivent Financial For Lutherans
- $45.7 Billion
- Q2 2025
A detailed history of Thrivent Financial For Lutherans transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 99,715 shares of TGTX stock, worth $3.41 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
99,715
Previous 98,038
1.71%
Holding current value
$3.41 Million
Previous $3.87 Million
7.17%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding TGTX
# of Institutions
407Shares Held
92.4MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$541 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$390 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$261 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$119 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$104 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.97B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...